Nath Bio-Genes (India)
Nath Bio-Genes (India) Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Nath Bio-Genes (India)
Start SIPNath Bio-Genes (India) Investment Rating
-
Master Rating:
-
Nath Bio Genes India has an operating revenue of Rs. 283.59 Cr. on a trailing 12-month basis. An annual revenue de-growth of -9% needs improvement, Pre-tax margin of -23% needs improvement, ROE of -12% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 27 which is a POOR score indicating inconsistency in earnings, a RS Rating of 32 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 44 indicates it belongs to a fair industry group of Agricultural Operations and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 25 | 22 | 209 | 27 |
| Operating Expenses Qtr Cr | 20 | 17 | 175 | 48 |
| Operating Profit Qtr Cr | 6 | 5 | 34 | -21 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 3 | 3 | 3 | 2 |
| Tax Qtr Cr | 1 | 0 | 0 | 3 |
| Net Profit Qtr Cr | 1 | 1 | 31 | -116 |
Nath Bio-Genes (India) Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 144.82
- 50 Day
- 149.27
- 100 Day
- 155.91
- 200 Day
- 172.2
- 20 Day
- 145.5
- 50 Day
- 149.29
- 100 Day
- 156.96
- 200 Day
- 165.84
Nath Bio-Genes (India) Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 140.65 |
| Second Resistance | 142.95 |
| Third Resistance | 144.25 |
| RSI | 32.91 |
| MFI | 30.41 |
| MACD Single Line | -1.78 |
| MACD | -2.38 |
| Support | |
|---|---|
| First Resistance | 137.06 |
| Second Resistance | 135.75 |
| Third Resistance | 133.45 |
Nath Bio-Genes (India) Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 9,141 | 881,832 | 96.47 |
| Week | 23,158 | 1,785,466 | 77.1 |
| 1 Month | 38,969 | 2,928,109 | 75.14 |
| 6 Month | 38,608 | 2,442,320 | 63.26 |
Nath Bio-Genes (India) Result Highlights
Nath Bio-Genes (India) Synopsis
NSE-Agricultural Operations
Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 278.36 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2022. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.| Market Cap | 267 |
| Sales | 284 |
| Shares in Float | 1.03 |
| No of funds | 13 |
| Yield | 1.45 |
| Book Value | 0.49 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | |
| Alpha | -0.13 |
| Beta | 1.15 |
Nath Bio-Genes (India)
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 45.6% | 45.6% | 41.07% | |
| Mutual Funds | 4.62% | 4.62% | 4.62% | |
| Foreign Portfolio Investors | 0.15% | 0.01% | 0.11% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 30.62% | 31.61% | 31.29% | |
| Others | 19.01% | 18.16% | 22.91% |
Nath Bio-Genes (India) Management
| Name | Designation |
|---|---|
| Mr. Satish Kagliwal | Managing Director |
| Mr. Madhukar Deshpande | Director |
| Ms. Ashu Jain | Director |
| Mr. Hitesh Purohit | Director |
| Mrs. Jeevanlata Kagliwal | Director |
| Mr. Vadla Nagabhushanam | Director |
| Mrs. Sweta Kagliwal | Director |
Nath Bio-Genes (India) Forecast
Price Estimates
Nath Bio-Genes (India) FAQs
What is Share Price of Nath Bio-Genes (India) ?
Nath Bio-Genes (India) share price is ₹140 As on 29 March, 2023 | 14:37
What is the Market Cap of Nath Bio-Genes (India) ?
The Market Cap of Nath Bio-Genes (India) is ₹267 Cr As on 29 March, 2023 | 14:37
What is the P/E ratio of Nath Bio-Genes (India) ?
The P/E ratio of Nath Bio-Genes (India) is -3.2 As on 29 March, 2023 | 14:37
What is the PB ratio of Nath Bio-Genes (India) ?
The PB ratio of Nath Bio-Genes (India) is 0.5 As on 29 March, 2023 | 14:37